Keywords: merck, co, januiva, non-inferior, metformin, late-breaking, oral

Merck & Co's Januiva: 'non-inferior to metformin'

Article | 13 June 2006

Print This

In a late-breaking oral presentation at the American Diabetes Association's 66th annual meeting held in Washington DC, US drug mjaor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in